ガバペンチンの世界市場予測2019-2024

LP Informationが発行した調査報告書(LPI9051419)
◆英語タイトル:Global Gabapentin Market Growth 2019-2024
◆商品コード:LPI9051419
◆発行会社(リサーチ会社):LP Information
◆発行日:2019年4月8日
◆ページ数:160
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥387,960見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥581,940見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥775,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「ガバペンチンの世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、カプセル、錠剤など、用途別には、Epilepsy、Neuropathic Pain、Restless Legs Syndrome、Othersなどに区分してまとめた調査レポートです。ガバペンチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向、販売チャネルなどの情報が含まれています。
・ガバペンチンの世界市場概要(サマリー)
・ガバペンチンの企業別販売量・売上
・ガバペンチンの企業別市場シェア
・ガバペンチンの世界市場規模:種類別(カプセル、錠剤)
・ガバペンチンの世界市場規模:用途別(Epilepsy、Neuropathic Pain、Restless Legs Syndrome、Others)
・ガバペンチンの米州市場規模(アメリカ、カナダ、メキシコなど)
・ガバペンチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ガバペンチンの欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ガバペンチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ガバペンチン市場の成長要因・課題・動向
・ガバペンチンの販売チャネル、流通業者、顧客
・ガバペンチンの世界市場予測
・ガバペンチンの米州市場予測(アメリカ、カナダ、メキシコなど)
・ガバペンチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ガバペンチンの欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ガバペンチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ガバペンチンの世界市場予測:種類別(カプセル、錠剤)
・ガバペンチンの世界市場予測:用途別(Epilepsy、Neuropathic Pain、Restless Legs Syndrome、Others)
・主要企業分析
【レポートの概要】

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.

According to this study, over the next five years the Gabapentin market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 1550 million by 2024, from US$ 1430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gabapentin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.

This study considers the Gabapentin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Depomed
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gabapentin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gabapentin market by identifying its various subsegments.
Focuses on the key global Gabapentin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gabapentin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gabapentin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

2019-2024 Global Gabapentin Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gabapentin Consumption 2014-2024
2.1.2 Gabapentin Consumption CAGR by Region
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Consumption by Type
2.3.1 Global Gabapentin Consumption Market Share by Type (2014-2019)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2014-2019)
2.3.3 Global Gabapentin Sale Price by Type (2014-2019)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Consumption by Application
2.5.1 Global Gabapentin Consumption Market Share by Application (2014-2019)
2.5.2 Global Gabapentin Value and Market Share by Application (2014-2019)
2.5.3 Global Gabapentin Sale Price by Application (2014-2019)

3 Global Gabapentin by Players
3.1 Global Gabapentin Sales Market Share by Players
3.1.1 Global Gabapentin Sales by Players (2017-2019)
3.1.2 Global Gabapentin Sales Market Share by Players (2017-2019)
3.2 Global Gabapentin Revenue Market Share by Players
3.2.1 Global Gabapentin Revenue by Players (2017-2019)
3.2.2 Global Gabapentin Revenue Market Share by Players (2017-2019)
3.3 Global Gabapentin Sale Price by Players
3.4 Global Gabapentin Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Gabapentin Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Gabapentin by Regions
4.1 Gabapentin by Regions
4.1.1 Global Gabapentin Consumption by Regions
4.1.2 Global Gabapentin Value by Regions
4.2 Americas Gabapentin Consumption Growth
4.3 APAC Gabapentin Consumption Growth
4.4 Europe Gabapentin Consumption Growth
4.5 Middle East & Africa Gabapentin Consumption Growth

5 Americas
5.1 Americas Gabapentin Consumption by Countries
5.1.1 Americas Gabapentin Consumption by Countries (2014-2019)
5.1.2 Americas Gabapentin Value by Countries (2014-2019)
5.2 Americas Gabapentin Consumption by Type
5.3 Americas Gabapentin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gabapentin Consumption by Countries
6.1.1 APAC Gabapentin Consumption by Countries (2014-2019)
6.1.2 APAC Gabapentin Value by Countries (2014-2019)
6.2 APAC Gabapentin Consumption by Type
6.3 APAC Gabapentin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gabapentin by Countries
7.1.1 Europe Gabapentin Consumption by Countries (2014-2019)
7.1.2 Europe Gabapentin Value by Countries (2014-2019)
7.2 Europe Gabapentin Consumption by Type
7.3 Europe Gabapentin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gabapentin by Countries
8.1.1 Middle East & Africa Gabapentin Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Gabapentin Value by Countries (2014-2019)
8.2 Middle East & Africa Gabapentin Consumption by Type
8.3 Middle East & Africa Gabapentin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gabapentin Distributors
10.3 Gabapentin Customer

11 Global Gabapentin Market Forecast
11.1 Global Gabapentin Consumption Forecast (2019-2024)
11.2 Global Gabapentin Forecast by Regions
11.2.1 Global Gabapentin Forecast by Regions (2019-2024)
11.2.2 Global Gabapentin Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gabapentin Forecast by Type
11.8 Global Gabapentin Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Gabapentin Product Offered
12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Depomed
12.2.1 Company Details
12.2.2 Gabapentin Product Offered
12.2.3 Depomed Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Depomed News
12.3 TEVA
12.3.1 Company Details
12.3.2 Gabapentin Product Offered
12.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 TEVA News
12.4 Mylan
12.4.1 Company Details
12.4.2 Gabapentin Product Offered
12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Arbor Pharma
12.5.1 Company Details
12.5.2 Gabapentin Product Offered
12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Arbor Pharma News
12.6 Novartis
12.6.1 Company Details
12.6.2 Gabapentin Product Offered
12.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Novartis News
12.7 Apotex
12.7.1 Company Details
12.7.2 Gabapentin Product Offered
12.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Apotex News
12.8 Sun Pharmaceutical
12.8.1 Company Details
12.8.2 Gabapentin Product Offered
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Sun Pharmaceutical News
12.9 Aurobindo Pharma
12.9.1 Company Details
12.9.2 Gabapentin Product Offered
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Aurobindo Pharma News
12.10 Intas
12.10.1 Company Details
12.10.2 Gabapentin Product Offered
12.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Intas News
12.11 Amneal
12.12 Marksans Pharma
12.13 Glenmark
12.14 Alkem
12.15 Jiangsu Enhua
12.16 Jiangsu Hengrui
12.17 Sailike

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ガバペンチンの世界市場予測2019-2024(Global Gabapentin Market Growth 2019-2024)]についてメールでお問い合わせはこちらでお願いします。